{"id":"levocetirizine-tablets","safety":{"commonSideEffects":[{"rate":"1.4%","effect":"Drowsiness"},{"rate":"2.4%","effect":"Headache"},{"rate":"1.1%","effect":"Fatigue"},{"rate":"0.9%","effect":"Dry mouth"},{"rate":"0.7%","effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL1201191","moleculeType":"Small molecule","molecularWeight":"388.90"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Levocetirizine is a non-sedative, second-generation antihistamine that selectively inhibits peripheral H1-receptors without significant anticholinergic or central nervous system side effects.","oneSentence":"Selective histamine H1 receptor antagonist","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:42:23.743Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Allergic rhinitis"},{"name":"Chronic urticaria"}]},"trialDetails":[{"nctId":"NCT05637710","phase":"PHASE3","title":"Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil","status":"WITHDRAWN","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-03","conditions":"Allergic Rhinitis","enrollment":""},{"nctId":"NCT03545464","phase":"PHASE3","title":"COrticosteroids in acUte uRticAria in emerGency dEpartment","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2019-09-21","conditions":"Urticaria, Angiœdema","enrollment":137},{"nctId":"NCT06816784","phase":"PHASE2","title":"Treatment Options for Chronic Urticaria","status":"NOT_YET_RECRUITING","sponsor":"Sheikh Zayed Medical College","startDate":"2025-02","conditions":"Chronic Urticaria","enrollment":72},{"nctId":"NCT00160680","phase":"PHASE4","title":"ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life)","status":"COMPLETED","sponsor":"UCB S.A. - Pharma Sector","startDate":"2005-03-01","conditions":"Rhinitis, Allergic, Perennial","enrollment":62},{"nctId":"NCT00359138","phase":"PHASE4","title":"The Duration of the Suppressive Effects of Desloratadine on Allergen Prick Tests After Discontinuation (P04441)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-02","conditions":"Hypersensitivity","enrollment":36},{"nctId":"NCT00621959","phase":"PHASE4","title":"A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2008-03","conditions":"Seasonal Allergic Rhinitis","enrollment":596},{"nctId":"NCT03555890","phase":"PHASE1","title":"Bioequivalence Study Between Levocetirizine Oral Disintegrating Tablet (ODT) and Levocetirizine Immediate Release Tablet (IRT)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2018-05-18","conditions":"Rhinitis","enrollment":72},{"nctId":"NCT04399525","phase":"NA","title":"Influence of H1-antihistamines on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin.","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2019-10-28","conditions":"Pruritus","enrollment":12},{"nctId":"NCT01586091","phase":"PHASE4","title":"Safety Study of Levocetirizine and Fexofenadine","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2011-02","conditions":"Pruritus, Chronic Urticaria, Allergic Rhinitis","enrollment":18},{"nctId":"NCT00679250","phase":"PHASE4","title":"To Evaluate Adenosine Monophosphate and Allergen Challenge in Allergic Rhinitis","status":"COMPLETED","sponsor":"Brian J Lipworth","startDate":"2005-11","conditions":"Allergic Rhinitis","enrollment":25},{"nctId":"NCT02372604","phase":"PHASE3","title":"Efficacy of Levocetirizine Fourfold Dosage in Chronic Spontaneous Urticaria","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2015-07","conditions":"Chronic Spontaneous Urticaria","enrollment":15},{"nctId":"NCT00295022","phase":"PHASE4","title":"Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing Seasonal Allergic Rhinitis (SAR) Symptoms in Ragweed Sensitive Subjects","status":"COMPLETED","sponsor":"UCB S.A. - Pharma Sector","startDate":"2006-07-29","conditions":"Rhinitis, Allergic, Seasonal","enrollment":418},{"nctId":"NCT00291642","phase":"PHASE2","title":"A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2006-01-01","conditions":"Rhinitis, Allergic, Seasonal","enrollment":551},{"nctId":"NCT01008592","phase":"","title":"The Effect of Levocetirizine on Inflammatory Mediators in Dermatographism","status":"TERMINATED","sponsor":"Wake Forest University","startDate":"2009-04","conditions":"Rhinitis, Urticaria","enrollment":11},{"nctId":"NCT02551536","phase":"PHASE4","title":"Montelukast and Fexofenadine Versus Montelukast and Levocetrizine Combination in Allergic Rhinitis","status":"COMPLETED","sponsor":"Indira Gandhi Medical College, Shimla","startDate":"2014-04","conditions":"Allergic Rhinitis","enrollment":70},{"nctId":"NCT01445262","phase":"","title":"Drug Use Investigation for XYZAL®","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-02","conditions":"Rhinitis, Allergic, Perennial and Seasonal","enrollment":10728},{"nctId":"NCT00150761","phase":"PHASE4","title":"Facial Thermography Study of Levocetirizine Versus Cetirizine","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2004-07","conditions":"Anti-allergic Agents","enrollment":60},{"nctId":"NCT00826943","phase":"PHASE4","title":"Is Levocetirizine Less Sedating Than Cetirizine?","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2009-01","conditions":"Allergic Rhinitis","enrollment":30},{"nctId":"NCT00544388","phase":"PHASE3","title":"Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive Subjects","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2004-04","conditions":"Rhinitis, Allergic, Seasonal","enrollment":570},{"nctId":"NCT00525278","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2003-08","conditions":"Rhinitis, Allergic, Seasonal","enrollment":67},{"nctId":"NCT00524836","phase":"PHASE3","title":"Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2003-09","conditions":"Rhinitis, Allergic, Perennial","enrollment":71},{"nctId":"NCT00521131","phase":"PHASE4","title":"Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2002-09","conditions":"Rhinitis, Allergic, Perennial","enrollment":453},{"nctId":"NCT00542607","phase":"PHASE4","title":"Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2002-09","conditions":"Rhinitis, Allergic, Seasonal","enrollment":94},{"nctId":"NCT00525382","phase":"PHASE3","title":"Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2003-08","conditions":"Urticaria","enrollment":134},{"nctId":"NCT00521040","phase":"NA","title":"Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SAR","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2004-02","conditions":"Rhinitis, Allergic, Seasonal","enrollment":459},{"nctId":"NCT00520754","phase":"PHASE2","title":"Efficacy and Safety of Levocetirizine for Treatment of Recurrent Cough Associated With Other Allergic Symptoms in Children","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2001-12","conditions":"Cough","enrollment":15},{"nctId":"NCT00884325","phase":"PHASE4","title":"Management of Pruritus With Xyzal in Atopic Dermatitis","status":"COMPLETED","sponsor":"Derm Research, PLLC","startDate":"2009-02","conditions":"Atopic Dermatitis, Pruritus","enrollment":40},{"nctId":"NCT01651481","phase":"PHASE1","title":"Study to Evaluate the Pharmacokinetics and Safety of Singulair and Xyzal in Free Combination and Fixed-dose Combination","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2012-07","conditions":"Rhinitis","enrollment":28},{"nctId":"NCT01509209","phase":"PHASE3","title":"Efficacy/Safety of Pseudoephedrine Plus Levocetirizine Versus Placebo in Patients With Vasomotor Rhinitis","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2011-05","conditions":"Vasomotor Rhinitis","enrollment":137},{"nctId":"NCT01640535","phase":"PHASE3","title":"Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2012-06","conditions":"Perennial Allergic Rhinitis","enrollment":283},{"nctId":"NCT01567501","phase":"PHASE1","title":"Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fed Condition","status":"COMPLETED","sponsor":"IPCA Laboratories Ltd.","startDate":"2012-02","conditions":"Fed","enrollment":28},{"nctId":"NCT01557439","phase":"PHASE1","title":"Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fasting Condition","status":"COMPLETED","sponsor":"IPCA Laboratories Ltd.","startDate":"2012-02","conditions":"Fasting State","enrollment":28},{"nctId":"NCT00421109","phase":"PHASE3","title":"Efficacy Study for the Symptomatic Treatment of Chronic Idiopathic Urticaria","status":"COMPLETED","sponsor":"Faes Farma, S.A.","startDate":"2006-07","conditions":"Urticaria","enrollment":522},{"nctId":"NCT01506063","phase":"PHASE1","title":"Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under Fed Conditions","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2008-01","conditions":"Healthy","enrollment":31},{"nctId":"NCT01506076","phase":"PHASE1","title":"Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under Fasting Conditions","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2007-12","conditions":"Fasting","enrollment":29},{"nctId":"NCT00653224","phase":"PHASE4","title":"A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2008-04","conditions":"Seasonal Allergic Rhinitis","enrollment":580},{"nctId":"NCT00375713","phase":"PHASE3","title":"Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and Eczema","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2005-10","conditions":"Dermatitis, Eczema","enrollment":466},{"nctId":"NCT01000792","phase":"PHASE3","title":"3-D Visualization of the Anti-Obstructive Effect of Levocetirizine","status":"COMPLETED","sponsor":"Clinical Research International Limited","startDate":"2009-11","conditions":"Allergic Rhinitis","enrollment":1},{"nctId":"NCT00894231","phase":"PHASE4","title":"Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic Rhinitis","status":"COMPLETED","sponsor":"AAADRS Clinical Research Center","startDate":"2009-01","conditions":"Perennial Allergic Rhinitis","enrollment":30},{"nctId":"NCT00355771","phase":"PHASE4","title":"Levocetirizine 5 mg: Reduction of Symptoms, Airway Resistance and Sleep Impairment in Persistent Allergic Rhinitis","status":"COMPLETED","sponsor":"Institut für Atemwegsforschung GmbH","startDate":"2006-06","conditions":"Allergic Rhinitis","enrollment":100},{"nctId":"NCT00439712","phase":"PHASE4","title":"Levocetirizine in the Treatment of Nasal Obstruction Due to Perennial Allergic Rhinitis","status":"COMPLETED","sponsor":"Institut für Atemwegsforschung GmbH","startDate":"2007-02","conditions":"Perennial Allergic Rhinitis","enrollment":60}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"ATRIOVENTRICULAR BLOCK SECOND DEGREE"},{"count":1,"reaction":"BLOOD PRESSURE INADEQUATELY CONTROLLED"},{"count":1,"reaction":"COELIAC DISEASE"},{"count":1,"reaction":"COMPLETED SUICIDE"},{"count":1,"reaction":"DIZZINESS"},{"count":1,"reaction":"DRUG DOSE OMISSION"},{"count":1,"reaction":"DRUG INEFFECTIVE"},{"count":1,"reaction":"DRUG INEFFECTIVE FOR UNAPPROVED INDICATION"},{"count":1,"reaction":"DYSPNOEA"},{"count":1,"reaction":"EYE SWELLING"}],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Xyzal"],"phase":"phase_2","status":"active","brandName":"Levocetirizine tablets","genericName":"Levocetirizine tablets","companyName":"UCB Pharma","companyId":"ucb-pharma","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Selective histamine H1 receptor antagonist Used for Allergic rhinitis, Chronic urticaria.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}